View More Recent Stories
-
BofA Securities Starts Perspective Therapeutics Inc (CATX) at Buy
-
Perspective Therapeutics Inc (CATX) PT Raised to $19 at Oppenheimer
-
RBC Capital Reiterates Outperform Rating on Perspective Therapeutics Inc (CATX)
-
Perspective Therapeutics (CATX) Announces 1-for-10 Reverse Stock Split


